These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9413696)

  • 21. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
    Jacobson MA
    AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
    [No Abstract]   [Full Text] [Related]  

  • 22. Sustained release intravitreal ganciclovir implant as salvage treatment in AIDS related cytomegalovirus retinitis.
    Kamal A; King A; Sylvestri G; Dhillon B
    Br J Ophthalmol; 1998 Mar; 82(3):333. PubMed ID: 9602643
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.
    Jabs DA; Enger C; Dunn JP; Forman M
    J Infect Dis; 1998 Mar; 177(3):770-3. PubMed ID: 9498461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.
    Bakshi NK; Fahle GA; Sereti I; Wiley H; Nussenblatt RB; Sen HN
    Eye (Lond); 2012 May; 26(5):759-60. PubMed ID: 22322999
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.
    Marx JL; Kapusta MA; Patel SS; LaBree LD; Walonker F; Rao NA; Chong LP
    Arch Ophthalmol; 1996 Jul; 114(7):815-20. PubMed ID: 8660164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganciclovir intraocular implant.
    Morley MG; Duker JS; Reichel E
    Ophthalmology; 1996 Oct; 103(10):1517. PubMed ID: 8874416
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New issues in the management of cytomegalovirus retinitis in AIDS patients.
    Pau AK
    Am J Health Syst Pharm; 1998 Feb; 55(4):392-5. PubMed ID: 9504201
    [No Abstract]   [Full Text] [Related]  

  • 30. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of cytomegalovirus retinitis with the intraocular ganciclovir implant.
    Anand R
    Curr Opin Ophthalmol; 1997 Jun; 8(3):8-14. PubMed ID: 10168898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term, successful maintenance of bilateral cytomegalovirus retinitis using exclusively local therapy.
    Duker JS; Ashton P; Davis JL; Keller R; Chuang E
    Arch Ophthalmol; 1996 Jul; 114(7):881-2. PubMed ID: 8660179
    [No Abstract]   [Full Text] [Related]  

  • 34. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
    Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drugs for treating CMV. Valcyte, an oral compound, expands the treatment options for people with CMV retinitis.
    Eagan L
    Posit Living; 2001; 10(6):13. PubMed ID: 11702748
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic decisions: informed choices in a changing clinical environment.
    Holland GN
    Am J Ophthalmol; 1999 Mar; 127(3):327-8. PubMed ID: 10088744
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant.
    Roth DB; Feuer WJ; Blenke AJ; Davis JL
    Am J Ophthalmol; 1999 Mar; 127(3):276-82. PubMed ID: 10088736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel.
    Martin DF; Dunn JP; Davis JL; Duker JS; Engstrom RE; Friedberg DN; Jaffe GJ; Kuppermann BD; Polis MA; Whitley RJ; Wolitz RA; Benson CA
    Am J Ophthalmol; 1999 Mar; 127(3):329-39. PubMed ID: 10088745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of pneumatic retinopexy to delay surgical repair of a retinal detachment associated with the ganciclovir intraocular device.
    McAuliffe PF; Heinemann MH
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):244-6. PubMed ID: 9547780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.